News and Events

Explore our latest news and events

News

Radiomedix

Macrocyclics produces cGMP peptide in support of NET clinical trial

November 1, 2016

Macrocyclics was contracted by Radiomedix and AREVA Med to produce the cGMP peptide conjugate that…

Read More

Macrocyclics Inaugurates New Production Facility

April 13, 2016

AREVA Med has launched operations at its second high-purity lead-212 (²¹²Pb) production facility…

Read More

New Plano Facility on Schedule to Open in 2nd Quarter of 2016

January 21, 2016

AREVA Med’s second high-purity lead-212 (²¹²Pb) production facility is now well advanced in…

Read More

Press Releases

Read All

AREVA Med Inaugurates Second Lead-212 Production Facility

April 13, 2016 - Plano, Texas

AREVA Med’s Second Production Facility on Schedule to Open in 2nd Quarter of 2016

January 21, 2016 - Plano, Texas

AREVA Med & RadioMedix partner to develop new treatment against Neuroendocrine Tumors with Lead-212

May 18, 2015 - Houston, Texas & Bethesda, Maryland

AREVA Med acquires Macrocyclics, Inc.

October 20, 2011 - Bethesda, Maryland

Events

10Jun

SNMMI – Society of Nuclear Medicine and Molecular Imaging 2017

Denver, CO

Please visit the Macrocyclics team at our booth between June 10 & June 14…

Read More

15Oct

EANM – European Association of Nuclear Medicine 2016 – October 15th-19th

Barcelona

Visit Macrocyclics at Booth #96

Read More